Total trials
72
Active
11
Phase 3
0
Total enrollment
7,232
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Ginger | — | — | — | — | — | 1 | |
| Adjustment of insulin doses DAR | — | — | — | — | — | 1 | |
| Adjustment of insulin doses CFT | — | — | — | — | — | 1 | |
| Intravenous Morphine | — | — | — | — | — | 1 | |
| Dexamathsone 4mg/ml associated with experimental arm | — | — | — | — | — | 1 | |
| Lidocaine IV | — | — | — | — | — | 1 | |
| Ketamine Injectable Solution | — | — | — | — | — | 1 |
Next readouts
- 2026-02-10
- 2026-03-01
- 2026-06-30
- 2026-06-30
- 2026-08
Top conditions
- Postoperative Pain6
- Hypotension4
- Adverse Effect3
- Anesthesia3
- Sjogren's Syndrome2
- Labor Pain2
- Anxiety2
- Hip Fracture2
Frequently asked questions about University Tunis El Manar
- How many clinical trials does University Tunis El Manar have on ClinicalTrials.gov?
- University Tunis El Manar is listed as the lead sponsor on 72 clinical trials in ClinicalTrials.gov, 11 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University Tunis El Manar's trials are in Phase 3?
- 0 of University Tunis El Manar's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does University Tunis El Manar focus on?
- University Tunis El Manar's most-studied conditions on ClinicalTrials.gov are Postoperative Pain, Hypotension, Adverse Effect, Anesthesia, Sjogren's Syndrome.
- When are University Tunis El Manar's next clinical trial readouts?
- University Tunis El Manar has 5 upcoming primary-completion readouts tracked here; the soonest is “Comparison of Intravenous Lidocaine vs Ketamine in Colorectal Surgery”, expected around 2026-02-10.